Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Risk factors for perinatal mortality in Murmansk County, Russia: a registry-based study.

Usynina AA, Grjibovski AM, Krettek A, Odland JØ, Kudryavtsev AV, Anda EE.

Glob Health Action. 2017;10(1):1270536. doi: 10.1080/16549716.2017.1270536.

2.

Specialist antenatal clinics for women at high risk of preterm birth: a systematic review of qualitative and quantitative research.

Malouf R, Redshaw M.

BMC Pregnancy Childbirth. 2017 Feb 2;17(1):51. doi: 10.1186/s12884-017-1232-9.

3.

Intrapartum Cervical Laceration and Subsequent Pregnancy Outcomes.

Wong LF, Wilkes J, Korgenski K, Varner MW, Manuck TA.

AJP Rep. 2016 Jul;6(3):e318-23. doi: 10.1055/s-0036-1592198.

4.

Nonresponse to 17-alpha hydroxyprogesterone caproate for recurrent spontaneous preterm birth prevention: clinical prediction and generation of a risk scoring system.

Manuck TA, Stoddard GJ, Fry RC, Esplin MS, Varner MW.

Am J Obstet Gynecol. 2016 Nov;215(5):622.e1-622.e8. doi: 10.1016/j.ajog.2016.07.013. Epub 2016 Jul 11.

PMID:
27418444
5.

LOW PRETERM BIRTH RATE WITH DECREASING EARLY NEONATAL MORTALITY IN BOSNIA AND HERZEGOVINA DURING 2007-2014.

Hudic I, Stray-Pedersen B, Skokic F, Fatusic Z, Zildzic-Moralic A, Skokic M, Fatusic J.

Mater Sociomed. 2016 Feb;28(1):32-5. doi: 10.5455/msm.2016.28.32-35. Epub 2016 Jan 30.

6.

The genomics of prematurity in an era of more precise clinical phenotyping: A review.

Manuck TA.

Semin Fetal Neonatal Med. 2016 Apr;21(2):89-93. doi: 10.1016/j.siny.2016.01.001. Epub 2016 Feb 3. Review.

7.

Predictors of response to 17-alpha hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.

Manuck TA, Esplin MS, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Varner MW, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Genomics and Proteomics Network for Preterm Birth Research (GPN-PBR)..

Am J Obstet Gynecol. 2016 Mar;214(3):376.e1-8. doi: 10.1016/j.ajog.2015.12.010. Epub 2015 Dec 12.

8.

Risk factors associated with preterm birth after a prior term delivery.

Wong LF, Wilkes J, Korgenski K, Varner MW, Manuck TA.

BJOG. 2016 Oct;123(11):1772-8. doi: 10.1111/1471-0528.13683. Epub 2015 Sep 28.

PMID:
26412012
9.

Predicting Preterm Labour: Current Status and Future Prospects.

Georgiou HM, Di Quinzio MK, Permezel M, Brennecke SP.

Dis Markers. 2015;2015:435014. doi: 10.1155/2015/435014. Epub 2015 Jun 15. Review.

10.

Cluster analysis of spontaneous preterm birth phenotypes identifies potential associations among preterm birth mechanisms.

Esplin MS, Manuck TA, Varner MW, Christensen B, Biggio J, Bukowski R, Parry S, Zhang H, Huang H, Andrews W, Saade G, Sadovsky Y, Reddy UM, Ilekis J.

Am J Obstet Gynecol. 2015 Sep;213(3):429.e1-9. doi: 10.1016/j.ajog.2015.06.011. Epub 2015 Jun 9.

11.

Prediction of outcome for transabdominal cerclage in women with cervical insufficiency.

Song JE, Lee KY, Son GH.

Biomed Res Int. 2015;2015:985764. doi: 10.1155/2015/985764. Epub 2015 Feb 25.

12.

Preterm birth risk at high altitude in Peru.

Levine LD, Gonzales GF, Tapia VL, Gasco M, Sammel MD, Srinivas SK, Ludmir J.

Am J Obstet Gynecol. 2015 Feb;212(2):210.e1-8. doi: 10.1016/j.ajog.2014.08.024. Epub 2014 Aug 27.

13.

First trimester biomarkers in the prediction of later pregnancy complications.

Kane SC, Costa Fda S, Brennecke S.

Biomed Res Int. 2014;2014:807196. doi: 10.1155/2014/807196. Epub 2014 Mar 30. Review.

14.

Pharmacogenomics of 17-alpha hydroxyprogesterone caproate for recurrent preterm birth prevention.

Manuck TA, Watkins WS, Moore B, Esplin MS, Varner MW, Jackson GM, Yandell M, Jorde L.

Am J Obstet Gynecol. 2014 Apr;210(4):321.e1-321.e21. doi: 10.1016/j.ajog.2014.01.013. Epub 2014 Mar 1.

15.

Prevention of recurrent preterm birth: role of the neonatal follow-up program.

Clark EA, Esplin S, Torres L, Turok D, Yoder BA, Varner MW, Winter S.

Matern Child Health J. 2014 May;18(4):858-63. doi: 10.1007/s10995-013-1311-0.

16.

Effect of interleukin-6 polymorphism on risk of preterm birth within population strata: a meta-analysis.

Wu W, Clark EA, Stoddard GJ, Watkins WS, Esplin MS, Manuck TA, Xing J, Varner MW, Jorde LB.

BMC Genet. 2013 Apr 25;14:30. doi: 10.1186/1471-2156-14-30.

17.

Recurrence of preterm birth and perinatal mortality in northern Tanzania: registry-based cohort study.

Mahande MJ, Daltveit AK, Obure J, Mmbaga BT, Masenga G, Manongi R, Lie RT.

Trop Med Int Health. 2013 Aug;18(8):962-7. doi: 10.1111/tmi.12111. Epub 2013 Apr 13.

18.

Premature delivery and the millennium development goal.

Nour NM.

Rev Obstet Gynecol. 2012;5(2):100-5.

19.

Evaluation of record linkage between a large healthcare provider and the Utah Population Database.

DuVall SL, Fraser AM, Rowe K, Thomas A, Mineau GP.

J Am Med Inform Assoc. 2012 Jun;19(e1):e54-9. Epub 2011 Sep 16.

20.

Mapping a new spontaneous preterm birth susceptibility gene, IGF1R, using linkage, haplotype sharing, and association analysis.

Haataja R, Karjalainen MK, Luukkonen A, Teramo K, Puttonen H, Ojaniemi M, Varilo T, Chaudhari BP, Plunkett J, Murray JC, McCarroll SA, Peltonen L, Muglia LJ, Palotie A, Hallman M.

PLoS Genet. 2011 Feb 3;7(2):e1001293. doi: 10.1371/journal.pgen.1001293.

Supplemental Content

Support Center